Autoimmunity Reviews

Papers
(The H4-Index of Autoimmunity Reviews is 44. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Editorial Board189
Janus kinase inhibitors in rheumatoid arthritis-associated interstitial lung disease: A systematic review and meta-analysis150
Lymphocyte activation gene-3 (LAG-3) regulatory T cells: An evolving biomarker for treatment response in autoimmune diseases139
The BAFF/APRIL system at the crossroads of B cell memory and autoimmune relapse: Implication into the therapeutic strategies126
A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence116
The Trm-Treg Axis as a tissue-encoded immune checkpoint in chronic inflammation and autoimmunity111
Issues in autoantibody tests used in the classification criteria for autoimmune rheumatic diseases: the laboratory autoimmunologist's perspective105
Endometriosis and autoimmunity100
T lymphocyte plasticity in chronic inflammatory diseases: The emerging role of the Ikaros family as a key Th17-Treg switch99
Editorial Board98
MTHFR polymorphisms in autoimmune diseases: Mechanistic and clinical perspectives96
Susac syndrome: A scoping review94
The role of musculoskeletal ultrasound in difficult-to-treat RA: Insights from a systematic literature review93
Disease-modifying strategies: Targeting protein kinases in multiple sclerosis and other autoimmune disorders85
Epidemiological patterns and in-hospital mortality in ANCA-associated vasculitis: Insights from Spain's National Health Data (2016–2022)83
Autoantibody internalization in myositis skeletal muscle: Emerging evidence, mechanistic insights, and therapeutic relevance80
Characteristics and risk factors for infection in patients with ANCA-associated vasculitis: A systematic review and meta-analysis79
Comment on “Meta-analysis of meteorological conditions and rheumatoid arthritis”78
Worsening of Graves' ophthalmopathy after SARS-CoV-2 mRNA vaccination74
Idiopathic pericarditis in 2025: Advances in diagnosis and therapeutic strategies71
Fecal microbiota transplantation in autoimmune diseases – An extensive paper on a pathogenetic therapy66
To treat or not to treat rheumatoid arthritis with glucocorticoids? A reheated debate63
Metabolic traits of T cells and the implications in autoimmune diseases62
A call for uniformity in reporting patient level details during description of ophthalmologic major relapse among giant cell arteritis studies. A comment on article by Aussedat M et al. “Epidemiology 61
Infectious agents breaking the immunological tolerance: The holy grail in rheumatoid arthritis reconsidered61
Editorial Board61
Homocysteine as a trigger and potential therapeutic target for autoimmune diseases56
Corrigendum to “Proportion of circulating T follicular helper cells in peripheral blood of systemic lupus erythematosus patients: A systematic review and meta-analysis” [Autoimmunity Reviews Volume 2455
Rebalancing redox homeostasis: A pivotal regulator of the cGAS-STING pathway in autoimmune diseases54
Understanding the effects of Janus kinase inhibitors on the cardiovascular system in comparison to main biological DMARDs in rheumatoid arthritis54
Autoimmune pre-disease52
STING-inflammasome axis in autoimmune diseases and inflammation-related disease52
Human abdominal aortic aneurysm (AAA): Evidence for an autoimmune antigen-driven disease.51
Psychiatric manifestations of autoimmune encephalitis51
Autoimmunity, diet and autophagy51
Conceiving complexity: Biological mechanisms underpinning the lasting effect of pregnancy on multiple sclerosis outcomes51
Metabolic heterogeneity in tumor microenvironment – A novel landmark for immunotherapy50
WITHDRAWN: Global incidence trends of autoimmune diseases from 1990 to 2021 and projections to 2050: A systemic analysis of the global burden of disease study 202147
Can anticoagulation be withdrawn in APS patients after aPL negativization?47
The immune system in Hashimoto's thyroiditis: Updating the current state of knowledge on potential therapies and animal model construction46
Advances in precision medicine in imaging and therapeutic strategies for psoriatic disease46
Dermatomyositis unleashed by immune checkpoint inhibitors. Three additional cases and a review of the literature46
Seronegative autoimmune diseases: A challenging diagnosis45
Editorial Board44
Specialized pro-resolving mediators and autoimmunity: Recent insights and future perspectives44
0.32663202285767